Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection (Q47685158)

4 February 2018

title

Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection (English)

1 reference

4 February 2018

1 reference

1 reference

Babak Khoshnood

2

0 references

author name string

Marc Péchevis

1

1 reference

4 February 2018

Laurent Buteau

3

1 reference

4 February 2018

Isabelle Durand

4

1 reference

4 February 2018

Yuliya Piquard

5

1 reference

4 February 2018

Antoine Lafuma

6

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

21

1 reference

4 February 2018

issue

25-26

1 reference

4 February 2018

page(s)

3556-3564

1 reference

4 February 2018

Intrafamilial clustering of hepatitis A

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

An outbreak of hepatitis A in a French day-care center and efforts to combat it

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Hepatitis A vaccine for secondary hepatitis A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Hepatitis A vaccine for secondary hepatitis A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Interruption of an outbreak of hepatitis A in two villages by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Six years' follow-up after hepatitis A vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Cost-effectiveness analysis of hepatitis A prevention in travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Cost effectiveness of hepatitis A prevention in France

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Hepatitis in day care centers: epidemiology and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Atypical clinical manifestations of hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Vaccination policy against hepatitis A in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Serologic investigation of an outbreak of hepatitis A in a rural day-care center

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

An epidemic of hepatitis A in an institution for young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Should British soldiers be vaccinated against hepatitis A? An economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

Hepatitis A vaccine for secondary hepatitis A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900424-9

7 January 2021

10.1016/S0264-410X(03)00424-9

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12922083

1 reference

4 February 2018